Volume | 355,667 |
|
|||||
News | (1) | ||||||
Day High | 21.60 | Low High |
|||||
Day Low | 20.50 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Fulgent Genetics Inc | FLGT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
20.50 | 20.50 | 21.60 | 21.50 | 21.24 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
7,149 | 355,667 | US$ 21.06 | US$ 7,491,787 | - | 19.88 - 44.09 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
17:00:13 | 10 | US$ 21.25 | USD |
Fulgent Genetics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
641.27M | 29.78M | - | 289.21M | -167.83M | -5.63 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Fulgent Genetics News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical FLGT Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 20.03 | 21.60 | 20.00 | 20.60 | 169,615 | 1.47 | 7.34% |
1 Month | 20.98 | 21.89 | 19.88 | 20.66 | 163,249 | 0.52 | 2.48% |
3 Months | 25.25 | 26.365 | 19.88 | 22.61 | 219,259 | -3.75 | -14.85% |
6 Months | 24.36 | 30.68 | 19.88 | 24.92 | 205,052 | -2.86 | -11.74% |
1 Year | 29.08 | 44.09 | 19.88 | 29.35 | 217,640 | -7.58 | -26.07% |
3 Years | 77.51 | 112.00 | 19.88 | 59.89 | 356,298 | -56.01 | -72.26% |
5 Years | 6.90 | 189.8899 | 4.712 | 59.64 | 510,190 | 14.60 | 211.59% |
Fulgent Genetics Description
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign. |